Try our Advanced Search for more refined results
Life Sciences - December, 2008
139 articles
- Int'l Plaintiffs Appeal Dismissal From Aredia MDL
- Doctor To Back Off Drug Trials Amid Ethics Probe
- CORRECTION: Actavis To Halt Production At 3 Plants
- Role Of Rule 10b5-1 Plans In Securities Litigation
- Judge OKs Class In K-Dur Reverse-Payment Suit
- FTC OKs $1.6B King, Alpharma Deal With Divestiture
- Hemispherx Suit Over Merger Attempt Resuscitated
- Injunction Affirmed In Stryker Screw Patent Case
- Bayer Hits Abbott With Patent Suit Over Humira
- Abbott's Humira Ad Makes Unsupported Claims: FDA
- Abbott Loses Bid To Erase $29M In Damages
- 9 Defendants Dismissed From Prempro Suits
- Lilly Clashes With Valeant Over Permax Liability Costs
- Bristol-Myers, States Settle Plavix Case For $1.1M
- Fearing Oversize Pills, KV Freezes Pill Shipments
- Dr. Reddy's Eyes 2012 Launch Of Generic Clarinex
- Forest's $65M Settlement Over Antidepressants OK'd
- Drug Cos. Settle Chewable Contraceptive Patent Suit
- FDA Issues Top Recall For Stryker Cranial Implants
- Teva Agrees To Sell Assets In $8.9B Merger With Barr
- Pfizer Ordered To Pay $39M In Trade Secrets Dispute
- NFL Appeals Injunction In Players' Suit Over Diet Pills
- MedImmune Targets 5 PDL Patents In Licensing Spat
- Judge Tosses Protein Patent Suit Against Genentech
- NJ Supreme Court Axes 'Super Lawyer' Ad Ban
- Shareholders Sue Mentor Over $1B Merger With J&J
- Despite Statute, Rite Aid Worker Can Sue: Judge
- Fed. Circ. Remands Guidant Patent Case For Damages
- Mentor Prevails In 1st ObTape Product Liability Trial
- Damages Reduced In Cardinal's $12.2M Suit V. Tyco
- Antitrust, Infringement Claims Split In Cardizem Suit
- FDA Orders Suicide Warnings On Epilepsy Drugs
- AstraZeneca To Add Defendant In Nexium Patent Suit
- Fired Amgen Lawyer Can Pursue Case In Court
- Meijer Reaches $13M Deal With Barr In Ovcon Case
- Increasing Antitrust Enforcement Under Obama?
- Lupin Settles Clarinex Suit With Schering
- Judge Refuses To Toss Class Claim In FedEx MDL
- Eli Lilly Continues Crusade Against Cymbalta Generics
- Fed. Circ. Issues Mixed Ruling In Apnea Patent Case
- Orchid Counters Roche Claims In Boniva Patent Suit
- CIBA Drags More J&J Products Into Lens Patent Spat
- Gilead Sues Teva Over Truvada ANDA
- Bayer To Pay $18.5M To Settle Baycol Securities MDL
- Ovation Hiked Drug Price Almost 1,300 Percent: FTC
- Apotex Adds New Patent Challenge In Boniva Dispute
- Schering Sues Orchid In Latest Clarinex Patent Suit
- 4th Circ. Upholds Dismissal Of Inspire Securities Suit
- St. Jude Hit With Patent Suit Over Pacemaker
- Glaxo's Zinc-Containing Denture Cream Unsafe: Suit
- Direct Buyers Seek Class Certification In Flonase Suit
- Additional Patent Term Adjustment Under Wyeth
- High Court OKs Use Of State Laws In Tobacco Suits
- IP Practice: Paul Hastings
- Senator Demands Details On Wyeth Journal Articles
- Fed. Circ. Upholds Validity Of Sanofi's Plavix Patent
- Healon D Maker Recalls Drug Over Inflammatory Toxin
- Takeda V. Mylan — Keeping Your Ducks In A Row
- Medtronic To Report Death Of InFuse User To FDA
- Wound VAC Patent Suit V. Smith & Nephew Expands
- FDA Weighs Lilly, Amgen Findings On Cancer Drugs
- Injunction Extended in NFL Players' Suit Over Pills
- Medtronic Hit With Securities Suit Over InFuse Sales
- Drug Industry Boosts Consumer Marketing Rules
- Perrigo, Sepracor Settle Clarinex Patent Suit
- Warning Irrelevant In Zocor Case V. Merck: 9th Circ.
- Fed. Circ., KSR and Pharmas: The First Year And A Half
- Merck Fails To Force Trial Of Bellwether Fosamax Case
- Texas Appeals Court Makes U-Turn In Vioxx Case
- Bowel Cleansers To Get Black Box Warning: FDA
- No Causation In Human Tissue MDL: Judge
- Top 10 ITC Developments For 2008
- Teva, Pfizer Both Score Wins In Detrol Patent Fight
- Bayer Gets Another Suit Dropped In Baycol MDL
- WL Gore Loses Bid To Invalidate Medtronic Patents
- AstraZeneca Fires 3rd Suit At Handa Over Seroquel
- Ramifications Of The Net MoneyIN Inc. Decision
- Orion Continues Patent Battle Against Generic Stalevo
- 2nd Circ. Upholds 3.5-Year Term For Ex-Impath Exec
- WFN To Stop Touting 'Disease-Fighting' Supplements
- Former Heller Antitrust Veteran Joins White & Case
- Hospira Recalls Potassium Chloride Over Mislabeling
- Class Action Over Pepsi Bottled Water Dismissed
- Morgan Lewis Snaps Up Seasoned Litigator
- The Grim Outlook For Business Method Patents
- Employment Practice: Paul Hastings
- 60,000 Bottles Added To StarCaps Diet Pill Recall
- Regulators Hit With $110M Suit Over Fluoride Pills
- Plaintiff Seeks To Revive FCA Suit V. Express Scripts
- Medtronic Willfully Infringed Disc Patent: Jury
- King Sues Sandoz Over Patent For Muscle Relaxant
- Fired Roche Worker Files Sexual Harassment Suit
- Device For Cardiac Bypass In Children Recalled
- Fed. Circ. Upholds $16.8M Fees Award For Takeda
- Negligence Claim On Foley's Tardy Filing Remains
- Leaps & Bounds: Notable Firm News
- Cases Mount Against Mentor Over Vaginal Implant
- Eli Lilly Fires Off Another Cymbalta Patent Suit
- KV Adds Sherman Act Counterclaims To Ritalin Suit
- Auxilium Sues Upsher-Smith Over Testim ANDA
- Roche, Dr. Reddy's Drop One Patent In Boniva Suit
- Johnson & Johnson In-House Counsel Joins Lovells
- Appeals Court Grills Patent Office Over Rules
- Judge Won't Enforce $100K Deal In Liver Failure Case
- Health Food Co. Selling Unauthorized Drugs: FDA Suit
- Skadden Takes Clifford Chance White Collar Trio
- J&J, CIBA To Head To Trial Over Contact Lens Patent
- Court Denies UK Agency's Appeal In Price-Fixing Spat
- Bayer May Face Canadian Class Action Over Trasylol
- Recalls, Investigation Result In KV Investors' Suit
- On The Docket: IP Cases To Follow In 2009
- Ohio Supreme Court Rules On Workers' Comp Claims
- How To Woo In-House Counsel In A Recession
- Health Cases To Watch In 2009
- Lupin Challenges Oscient's Cholesterol Drug Patent
- Biogen Sues USPTO Over Patent Term Adjustment
- Innohep Possibly Unsafe For Elderly Patients: FDA
- Competition Cases To Watch In 2009
- Medtronic's Bone Graft Product Caused Death: Suit
- USPTO Appeals Wyeth Patent Term Adjustment Ruling
- Molecular Insight Hits USPTO Over Patent Terms
- Glenmark Lobs Counterclaims At Teva In Coreg Suit
- Mylan, Novartis Settle Spat Over Femara Generic
- EU Extends Inspection Of Teva-Barr Deal
- Solvay Sues USPTO Over Refusal To Extend Patent
- Impax, Medicis Clear Up Acne Patent Dispute
- Ky. High Court Upholds $7.8M Verdict In Parlodel Suit
- Life Sciences Brace For Aftermath Of Bilski
- Cutera Securities Plaintiffs Plot Appeal
- NY AG Honcho Moves To Labaton Sucharow
- Leiner Seeks To Buy Time To Appease IRS, Buyer
- Vulnerability Or Validity: Which Standard Is Correct?
- Zimmer Wins Summary Judgment In Implant Suit
- Is A Substantial Question Of Validity Enough?
- EU Attack On Drug IP Practices Presents Challenges
- In Pharma Cases, Injunctions Are In Public Interest
- Despite Melamine, Infant Formula Safe: FDA
- Plaintiff Granted Dismissal In Chantix Class Action
- Obama, Holder Hint At Justice Priorities